Mirae Asset Global ETFs Holdings
FHTX icon

Mirae Asset Global ETFs Holdings’s Foghorn Therapeutics FHTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.6K Buy
16,236
+374
+2% +$2.05K ﹤0.01% 2776
2025
Q4 		$85.7K Buy
15,862
+484
+3% +$2.19K ﹤0.01% 2739
2025
Q3 		$75.2K Sell
15,378
-2,530
-14% -$13.4K ﹤0.01% 2800
2025
Q2 		$84.2K Buy
17,908
+2,812
+19% +$11.8K ﹤0.01% 2693
2025
Q1 		$55.1K Buy
15,096
+624
+4% +$2.85K ﹤0.01% 2828
2024
Q4 		$68.3K Buy
14,472
+608
+4% +$4.43K ﹤0.01% 2836
2024
Q3 		$129K Buy
13,864
+4,102
+42% +$29.7K ﹤0.01% 2582
2024
Q2 		$56.1K Buy
+9,762
New +$58.1K ﹤0.01% 2762

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's FHTX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Foghorn Therapeutics (FHTX) stake by 2.4% in Q1 2026, buying an estimated $2.05K and bringing the position to 16,236 shares worth $77.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2776.

Mirae Asset Global ETFs Holdings first reported a position in FHTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $129K in Q3 2024. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 16,236 shares of Foghorn Therapeutics worth $77.6K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 374 Foghorn Therapeutics shares in Q1 2026, an estimated $2.05K.
  • Foghorn Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2776 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Foghorn Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Foghorn Therapeutics position peaked at $129K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.